Quan Jing Wang·2026-01-06 03:50Core Insights - The competition for brain-computer interface (BCI) technology is intensifying, with significant implications for human interaction and technology, comparable to the advent of the internet [1] - China is making strategic investments in BCI technology, aiming to establish itself as a leader in this emerging field [5] Technology Overview - BCI technology establishes a direct connection between the brain and external devices, translating neural signals into commands for machines, enabling functionalities like mobility for paralyzed individuals and communication for those unable to speak [2] - There are three main types of BCI technologies: non-invasive, semi-invasive, and invasive, each with varying levels of risk and signal quality [3] Industry Development - By 2025, China aims to achieve significant breakthroughs in BCI technology, with plans to create several industrial clusters and nurture global leaders in the field by 2030 [5] - The inclusion of BCI in China's national economic planning marks a shift from research to a strategic focus on technological advancement [5] Clinical Advancements - Clinical trials for invasive BCI technologies are progressing, with companies like Neuralink and domestic firms achieving significant milestones in patient treatments [6][7] - Non-invasive BCI applications are also expanding in medical and consumer markets, with several companies preparing to launch products [7] Market Growth - The global BCI market is projected to grow from $1.2 billion in 2019 to nearly $2 billion in 2023, with a compound annual growth rate (CAGR) exceeding 13% [9] - China's BCI market is expected to reach approximately $3.2 billion in 2024, with further growth anticipated [10] Investment Landscape - Investment in the BCI sector has seen fluctuations, with a peak in 2021-2022, but is expected to rebound due to supportive policies and government initiatives [11] - Most funding is directed towards invasive BCI solutions, with a significant number of investments occurring in early-stage rounds [11] Key Players - Companies involved in BCI technology span various sectors, including those focused on core components like electrodes and chips, as well as those developing applications in healthcare and consumer products [13][14][15] - Notable companies include Sanbo Brain Science, which has participated in pioneering clinical trials, and Yingqu Technology, a leading player in BCI device sales [17][18]